PharmaEssentia

<.htmL>

	Ko-Chung Lin, Ph.D. Founder and CEO Dr. Lin, the leading founder of PharmaEssentia Corp., is an accomplished scientist with more than 17 years of successful industrial experience in drug discovery and development. As a co-founder of discovery chemistry team at Biogen, he led the team to discover their first drug candidate that was later licensed to Merck Co. Prior to that, his work at Monsanto-Searle on HIV protease inhibitor project resulted in an AIDS drug on the market. Dr. Lin holds a Ph.D. from University of Missouri, followed by postdoctoral research at University of Michigan, and is the inventor of more than 30 patents.
	Ching-Leou Teng, Ph.D. Executive Vice President, Operation Dr. Teng obtained her Ph.D. from the University of Michigan, where she focused on drug absorption. Following two years' post-doctoral research, Dr. Teng joined the US FDA as a reviewer in pharmacokinetics, and then worked for a US-based biotech company focusing on new drug development, dosage form evaluation, manufacturing and process validation, and CMC section preparation for IND and NDA.
	Jack Hwang, Ph.D. Vice President, Development Chemistry Dr. Hwang, who holds a Ph.D. from the University of Pennsylvania, was a senior director at San Diego-based Optimer Pharmaceuticals prior to joining PharmaEssentia. Previously, he also worked for Ligand Pharmaceutical, Amgen and Array Biopharma. Dr. Hwang has authored 37 scientific papers and 17 patents.
	Shu-Fen Li , MBA Director, Business Development and Strategic Planning Ms. Li has a wealth of experience in international venture capital fund raising, marketing, product pricing, licensing and corporate strategic planning. She began her career in Yuan-Ta Securities Group in Taiwan, then utilized her overseas educations and experience by working in Siemens AG in Germany, after which she joined Financial Service International Corp. as well as Trade Compass, a Federal Express start-up, two companies located in the USA. Ms. Li holds an MBA from Seattle Pacific University, USA. She also studied at Harvard University for healthcare marketplace and general management-related courses between 2007 and 2008.
	James Lee, Ph.D. Executive Director, Analytical & QC Dr. Lee holds a Ph.D. from the University of Michigan. Prior joining PharmaEssentia, Dr. Lee has over 20 years of extensive industrial experience in analytical method development for small molecules, protein analysis and characterization as well as project management. He worked at the Children's Hospital of Philadelphia, Merck and Bayer for many years, led analytical method development, product characterization in support of R&D, process development, and quality control under cGMP/GLP.